BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 21503826)

  • 1. IGHV gene rearrangements as outcome predictors for CLL patients: experience of Ukrainian group.
    Kryachok I; Abramenko I; Bilous N; Chumak A; Martina Z; Filonenko I
    Med Oncol; 2012 Jun; 29(2):1093-101. PubMed ID: 21503826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular and clinical features of chronic lymphocytic leukaemia with stereotyped B cell receptors: results from an Italian multicentre study.
    Bomben R; Dal Bo M; Capello D; Forconi F; Maffei R; Laurenti L; Rossi D; Del Principe MI; Zucchetto A; Bertoni F; Rossi FM; Bulian P; Cattarossi I; Ilariucci F; Sozzi E; Spina V; Zucca E; Degan M; Lauria F; Del Poeta G; Efremov DG; Marasca R; Gaidano G; Gattei V
    Br J Haematol; 2009 Feb; 144(4):492-506. PubMed ID: 19036101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutational status and gene repertoire of IGHV-IGHD-IGHJ rearrangements in Serbian patients with chronic lymphocytic leukemia.
    Karan-Djurasevic T; Palibrk V; Kostic T; Spasovski V; Nikcevic G; Srzentic S; Colovic M; Colovic N; Vidovic A; Antic D; Mihaljevic B; Pavlovic S; Tosic N
    Clin Lymphoma Myeloma Leuk; 2012 Aug; 12(4):252-60. PubMed ID: 22560084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoglobulin heavy chain variable region gene repertoire and B-cell receptor stereotypes in Indian patients with chronic lymphocytic leukemia.
    Rani L; Mathur N; Gogia A; Vishnubhatla S; Kumar L; Sharma A; Dube D; Kaur P; Gupta R
    Leuk Lymphoma; 2016 Oct; 57(10):2389-400. PubMed ID: 26942309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The
    Perez-Chacon G; Zapata JM
    Front Immunol; 2021; 12():627602. PubMed ID: 33912159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoglobulin gene rearrangements and mutational status in argentinian patients with chronic lymphocytic leukemia.
    Stanganelli C; Travella A; Bezares R; Slavutsky I
    Clin Lymphoma Myeloma Leuk; 2013 Aug; 13(4):447-457.e2. PubMed ID: 23665144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoglobulin heavy chain variable region gene usage and mutational status of the leukemic B cells in Iranian patients with chronic lymphocytic leukemia.
    Hojjat-Farsangi M; Jeddi-Tehrani M; Razavi SM; Sharifian RA; Mellstedt H; Shokri F; Rabbani H
    Cancer Sci; 2009 Dec; 100(12):2346-53. PubMed ID: 19824994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. STEREOTYPED CASES IN UKRAINIAN COHORT OF CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS DEPENDING ON THE IONIZING RADIATION EXPOSURE.
    Bilous NI; Abramenko IV; Chumak AA; Dyagil IS; Martina ZV
    Probl Radiac Med Radiobiol; 2022 Dec; 27():307-323. PubMed ID: 36582097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IGHV3-21 gene expression in patients with B-cell chronic lymphocytic leukemia in Ukraine.
    Abramenko I; Bilous N; Kryachok I; Filonenko I; Pilipenko G; Chumak A; Bazyka D; Bebeshko V
    Exp Oncol; 2007 Sep; 29(3):226-30. PubMed ID: 18004251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of mutated IGHV3-23 genes in chronic lymphocytic leukemia identifies a disease subset with peculiar clinical and biological features.
    Bomben R; Dal-Bo M; Benedetti D; Capello D; Forconi F; Marconi D; Bertoni F; Maffei R; Laurenti L; Rossi D; Del Principe MI; Luciano F; Sozzi E; Cattarossi I; Zucchetto A; Rossi FM; Bulian P; Zucca E; Nicoloso MS; Degan M; Marasca R; Efremov DG; Del Poeta G; Gaidano G; Gattei V
    Clin Cancer Res; 2010 Jan; 16(2):620-8. PubMed ID: 20068100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoglobulin gene rearrangements in Chinese and Italian patients with chronic lymphocytic leukemia.
    Marinelli M; Ilari C; Xia Y; Del Giudice I; Cafforio L; Della Starza I; Raponi S; Mariglia P; Bonina S; Yu Z; Yang W; Qiu L; Chan T; Piciocchi A; Kwong YL; Tse E; Li J; Guarini A; Xu W; Foà R
    Oncotarget; 2016 Apr; 7(15):20520-31. PubMed ID: 26943037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Geographic patterns and pathogenetic implications of IGHV gene usage in chronic lymphocytic leukemia: the lesson of the IGHV3-21 gene.
    Ghia P; Stamatopoulos K; Belessi C; Moreno C; Stella S; Guida G; Michel A; Crespo M; Laoutaris N; Montserrat E; Anagnostopoulos A; Dighiero G; Fassas A; Caligaris-Cappio F; Davi F
    Blood; 2005 Feb; 105(4):1678-85. PubMed ID: 15466924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Light Chain IgLV3-21 Defines a New Poor Prognostic Subgroup in Chronic Lymphocytic Leukemia: Results of a Multicenter Study.
    Stamatopoulos B; Smith T; Crompot E; Pieters K; Clifford R; Mraz M; Robbe P; Burns A; Timbs A; Bruce D; Hillmen P; Meuleman N; Mineur P; Firescu R; Maerevoet M; De Wilde V; Efira A; Philippé J; Verhasselt B; Offner F; Sims D; Heger A; Dreau H; Schuh A
    Clin Cancer Res; 2018 Oct; 24(20):5048-5057. PubMed ID: 29945996
    [No Abstract]   [Full Text] [Related]  

  • 14. Repertoire of Rearranged Immunoglobulin Heavy Chain Genes in Russian Patients With B-Cell Lymphoproliferative Diseases.
    Biderman BV; Likold EB; Smirnova SY; Nikitin EA; Koroleva DA; Zvonkov EE; Al-Radi LS; Julhakyan HL; Sudarikov AB
    Clin Lymphoma Myeloma Leuk; 2021 Dec; 21(12):e938-e945. PubMed ID: 34384734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The signs of negative selection in IGHV framework regions are associated with worse overall survival of chronic lymphocytic leukemia patients.
    Abramenko I; Bilous N; Chumak A; Kryachok I; Fedorenko Z; Martina Z; Dyagil I
    Leuk Res; 2021 Nov; 110():106686. PubMed ID: 34492598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B-cell receptor, clinical course and prognosis in chronic lymphocytic leukaemia: the growing saga of the IGHV3 subgroup gene usage.
    Dal-Bo M; Del Giudice I; Bomben R; Capello D; Bertoni F; Forconi F; Laurenti L; Rossi D; Zucchetto A; Pozzato G; Marasca R; Efremov DG; Guarini A; Del Poeta G; Foà R; Gaidano G; Gattei V
    Br J Haematol; 2011 Apr; 153(1):3-14. PubMed ID: 21303354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Redefining the prognostic likelihood of chronic lymphocytic leukaemia patients with borderline percentage of immunoglobulin variable heavy chain region mutations.
    Raponi S; Ilari C; Della Starza I; Cappelli LV; Cafforio L; Piciocchi A; Arena V; Mariglia P; Mauro FR; Gentile M; Cutrona G; Moia R; Favini C; Morabito F; Rossi D; Gaidano G; Guarini A; Del Giudice I; Foà R
    Br J Haematol; 2020 Jun; 189(5):853-859. PubMed ID: 32064595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraclonal cell expansion and selection driven by B cell receptor in chronic lymphocytic leukemia.
    Colombo M; Cutrona G; Reverberi D; Fabris S; Neri A; Fabbi M; Quintana G; Quarta G; Ghiotto F; Fais F; Ferrarini M
    Mol Med; 2011; 17(7-8):834-9. PubMed ID: 21541442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular and clinical features of chronic lymphocytic leukemia with stereotyped B-cell receptors in a Ukrainian cohort.
    Bilous N; Bomben R; Dal Bo M; Capello D; Forconi F; Laurenti L; Bertoni F; Efremov DG; Marasca R; Del Poeta G; Martina Z; Kryachouk I; Dyagil I; Gaidano G; Chumak A; Gattei V; Abramenko I
    Leuk Lymphoma; 2010 May; 51(5):822-38. PubMed ID: 20233059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High expression of lymphocyte-activation gene 3 (LAG3) in chronic lymphocytic leukemia cells is associated with unmutated immunoglobulin variable heavy chain region (IGHV) gene and reduced treatment-free survival.
    Kotaskova J; Tichy B; Trbusek M; Francova HS; Kabathova J; Malcikova J; Doubek M; Brychtova Y; Mayer J; Pospisilova S
    J Mol Diagn; 2010 May; 12(3):328-34. PubMed ID: 20228263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.